JACLYN BATES: Open Payments
NPI 1184994238 · ROCKINGHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 39 payments from 14 companies in 2025. Trend: 2023 $762 · 2024 $924 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $195 |
| AstraZeneca Pharmaceuticals LP | 6 | $169 |
| Lilly USA, LLC | 4 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| ABBVIE INC. | 2 | $29 |
| Exact Sciences Corporation | 2 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
Products named: AIRSUPRA, Wegovy, Ozempic, MOUNJARO, Rybelsus, BREZTRI, JARDIANCE, FARXIGA.
Industry payments across NC — which companies pay providers there.
